Some post this informations on CEO. Ca/tlt
This could be US. https://ceo.ca/@newswire/oncolytics-biotech-announces-positive-clinical-results-31108 I do agree with his options, our share price should sit north of $4.5 instead... And beyond. Because we finished the Phase1b human trial more than 2 years ago with great success, while onc. To is just undertaking right now... Besides, we have Phase2b FTD status....